Sequoia Financial Advisors, LLC Alkermes Plc. Transaction History
Sequoia Financial Advisors, LLC
- $11.6 Billion
- Q1 2025
A detailed history of Sequoia Financial Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 6,222 shares of ALKS stock, worth $193,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,222
Previous 7,474
16.75%
Holding current value
$193,753
Previous $214,000
4.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$906 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$567 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$367 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$250 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$214 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.11B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...